{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:43:47Z","timestamp":1790930627406,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":6542,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1017\/s1041610207006485","type":"journal-article","created":{"date-parts":[[2007,12,12]],"date-time":"2007-12-12T08:51:51Z","timestamp":1197449511000},"page":"47-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Hormonal treatment, mild cognitive impairment and Alzheimer's disease"],"prefix":"10.1016","volume":"20","author":[{"given":"Joanne","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline","family":"Scali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Carriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Ancelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610207006485_bb0010","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.2174\/138161205774913228","article-title":"Lifelong endocrine fluctuations and related cognitive disorders","volume":"11","author":"Ancelin","year":"2005","journal-title":"Current Pharmaceutical Design"},{"key":"10.1017\/S1041610207006485_bb0015","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1017\/S1041610207006485_bb0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrn846","article-title":"Oestrogen as a neuroprotective hormone","volume":"3","author":"Behl","year":"2002","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1017\/S1041610207006485_bb0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/bbrc.1999.1665","article-title":"Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease","volume":"265","author":"Brandi","year":"1999","journal-title":"Biochemical Biophysical Research Communications"},{"key":"10.1017\/S1041610207006485_bb0030","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.mp.4001553","article-title":"Variations in estrogen receptor alpha gene and risk of dementia, and brain volumes on MRI","volume":"9","author":"den Heijer","year":"2004","journal-title":"Molecular Psychiatry"},{"key":"10.1017\/S1041610207006485_bb0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.psyneuen.2004.09.002","article-title":"Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women","volume":"30","author":"Dunkin","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1017\/S1041610207006485_bb0040","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archneur.59.10.1589","article-title":"Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn","volume":"59","author":"Edland","year":"2002","journal-title":"Archives of Neurology"},{"key":"10.1017\/S1041610207006485_bb0045","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1001\/jama.291.24.2959","article-title":"Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study","volume":"291","author":"Espeland","year":"2004","journal-title":"JAMA"},{"key":"10.1017\/S1041610207006485_bb0050","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.gme.0000188735.61994.5b","article-title":"When is it appropriate to prescribe postmenopausal hormone therapy?","volume":"13","author":"Ettinger","year":"2006","journal-title":"Menopause"},{"key":"10.1017\/S1041610207006485_bb0055","first-page":"CD004143","author":"Farquhar","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1017\/S1041610207006485_bb0060","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/sj.ejhg.5200714","article-title":"Investigations of a CA repeat in the oestrogen receptor beta gene in patients with Alzheimer's disease","volume":"9","author":"Forsell","year":"2001","journal-title":"European Journal of Human Genetics"},{"key":"10.1017\/S1041610207006485_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500042417","article-title":"KEEPS: The Kronos Early Estrogen Prevention Study","volume":"8","author":"Harman","year":"2005","journal-title":"Climacteric"},{"key":"10.1017\/S1041610207006485_bb0070","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0306-4522(00)00410-3","article-title":"The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis","volume":"101","author":"Hogervorst","year":"2000","journal-title":"Neuroscience"},{"key":"10.1017\/S1041610207006485_bb0075","first-page":"CD0037","author":"Hogervorst","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1017\/S1041610207006485_bb0080","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1468-1331.1999.640431.x","article-title":"Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia","volume":"6","author":"Isoe-Wada","year":"1999","journal-title":"European Journal of Neurology"},{"key":"10.1017\/S1041610207006485_bb0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000017224","article-title":"Estrogen receptor gene polymorphisms in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia","volume":"11","author":"Ji","year":"2000","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1017\/S1041610207006485_bb0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/01.gme.0000196592.36711.a0","article-title":"Cognitive function across the life course and the menopausal transition in a British birth cohort","volume":"13","author":"Kok","year":"2006","journal-title":"Menopause"},{"key":"10.1017\/S1041610207006485_bb0095","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.amjmed.2006.07.030","article-title":"Cognitive functioning and sex steroid hormone gene polymorphisms in women at midlife","volume":"119","author":"Kravitz","year":"2006","journal-title":"American Journal of Medicine"},{"key":"10.1017\/S1041610207006485_bb0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3940(01)01806-7","article-title":"Are the estrogen receptors involved in Alzheimer's disease?","volume":"306","author":"Lambert","year":"2001","journal-title":"Neuroscience Letters"},{"key":"10.1017\/S1041610207006485_bb0105","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.285.11.1489","article-title":"Hormone replacement therapy and cognition: systematic review and meta-analysis","volume":"285","author":"Leblanc","year":"2001","journal-title":"JAMA"},{"key":"10.1017\/S1041610207006485_bb0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.gme.0000191204.38664.61","article-title":"Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study","volume":"13","author":"MacLennan","year":"2006","journal-title":"Menopause"},{"key":"10.1017\/S1041610207006485_bb0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1521-690X(02)00082-9","article-title":"The menopause and HRT. HRT and cognitive decline","volume":"17","author":"Maki","year":"2003","journal-title":"Best Practice & Research Clinical Endocrinology & Metabolism"},{"key":"10.1017\/S1041610207006485_bb0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.273.5271.50","article-title":"Searching for drugs that combat Alzheimer's","volume":"273","author":"Marx","year":"1996","journal-title":"Science"},{"key":"10.1017\/S1041610207006485_bb0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.ypg.0000194445.27555.71","article-title":"Estrogen receptor alpha and risk for cognitive impairment in postmenopausal women","volume":"16","author":"Olsen","year":"2006","journal-title":"Psychiatric Genetics"},{"key":"10.1017\/S1041610207006485_bb0130","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.ejhg.5201447","article-title":"Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women","volume":"13","author":"Pirskanen","year":"2005","journal-title":"European Journal of Human Genetics"},{"key":"10.1017\/S1041610207006485_bb0135","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1001\/jama.289.20.2663","article-title":"Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Rapp","year":"2003","journal-title":"JAMA"},{"key":"10.1017\/S1041610207006485_bb0140","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.psyneuen.2005.01.004","article-title":"Endogenous and exogenous hormone exposure and risk of cognitive impairment in Swedish twins: a preliminary study","volume":"30","author":"Rasgon","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1017\/S1041610207006485_bb0145","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2005-2097","article-title":"Effects of combination estrogen plus progestin hormone treatment on cognition and affect","volume":"91","author":"Resnick","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1017\/S1041610207006485_bb0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1212\/WNL.60.1.148-a","article-title":"No additional benefit of HRT on response to rivastigmine in menopausal women with AD","volume":"60","author":"Rigaud","year":"2003","journal-title":"Neurology"},{"key":"10.1017\/S1041610207006485_bb0155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1192\/bjp.184.2.147","article-title":"Prevalence of DSM-IV psychiatric disorder in the French elderly population","volume":"184","author":"Ritchie","year":"2004","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610207006485_bb0160","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/bmj.326.7384.322","article-title":"Making decisions about hormone replacement therapy","volume":"326","author":"Rymer","year":"2003","journal-title":"BMJ"},{"key":"10.1017\/S1041610207006485_bb0165","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1212\/WNL.46.6.1580","article-title":"Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease","volume":"46","author":"Schneider","year":"1996","journal-title":"Neurology"},{"key":"10.1017\/S1041610207006485_bb0170","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"10.1017\/S1041610207006485_bb0175","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study","volume":"291","author":"Shumaker","year":"2004","journal-title":"JAMA"},{"key":"10.1017\/S1041610207006485_bb0180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.maturitas.2005.02.019","article-title":"Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004\/2005 position statements on peri- and postmenopausal hormone replacement therapy","volume":"51","author":"Skouby","year":"2005","journal-title":"Maturitas"},{"key":"10.1017\/S1041610207006485_bb0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3143\/geriatrics.38.117","article-title":"Causative genes in Alzheimer's disease [in Japanese]","volume":"38","author":"Urakami","year":"2001","journal-title":"Nippon Ronen Igakkai Zasshi"},{"key":"10.1017\/S1041610207006485_bb0190","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000091437","article-title":"No genetic association between the myeloperoxidase gene -463 polymorphism and estrogen receptor-alpha gene polymorphisms and Japanese sporadic Alzheimer's disease","volume":"21","author":"Usui","year":"2006","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1017\/S1041610207006485_bb0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00002093-200304000-00002","article-title":"The magnitude of dementia occurrence in the world","volume":"17","author":"Wimo","year":"2003","journal-title":"Alzheimer Diseases and Associated Disorders"},{"key":"10.1017\/S1041610207006485_bb0200","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"key":"10.1017\/S1041610207006485_bb0205","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/jama.279.9.688","article-title":"Estrogen therapy in postmenopausal women: effects on cognitive function and dementia","volume":"279","author":"Yaffe","year":"1998","journal-title":"JAMA"},{"key":"10.1017\/S1041610207006485_bb0210","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0006-3223(01)01289-6","article-title":"Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women","volume":"51","author":"Yaffe","year":"2002","journal-title":"Biological Psychiatry"},{"key":"10.1017\/S1041610207006485_bb0215","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1001\/jama.288.17.2123","article-title":"Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study","volume":"288","author":"Zandi","year":"2002","journal-title":"JAMA"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224052049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224052049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610207006485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T17:59:13Z","timestamp":1744394353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224052049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S1041610224052049"],"URL":"https:\/\/doi.org\/10.1017\/s1041610207006485","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormonal treatment, mild cognitive impairment and Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610207006485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Copyright \u00a9 International Psychogeriatric Association 2007. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}